Rankings
▼
Calendar
AMRX FY 2017 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMRX
Amneal Pharmaceuticals, Inc.
$4B
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.0B
+1.5% YoY
Gross Profit
$526M
50.9% margin
Operating Income
$245M
23.7% margin
Net Income
$168M
16.2% margin
EPS (Diluted)
$1.46
Cash Flow
Operating Cash Flow
$234M
Free Cash Flow
$120M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$1.7B
Stockholders' Equity
-$386M
Cash & Equivalents
$74M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.0B
$1.0B
+1.5%
Gross Profit
$526M
$597M
-11.9%
Operating Income
$245M
$285M
-14.0%
Net Income
$168M
$207M
-19.2%
← Q4 2016
All Quarters
Q1 2017 →